1111735-05-7

Basic information

• Product Name: 3-(4-aminophenyl)oxetan-3-ol
• Synonyms: 3-(4-aminophenyl)oxetan-3-ol
• CAS NO: 1111735-05-7
• Molecular Weight: 165.192
• Mol File: 1111735-05-7.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 3-(4-aminophenyl)oxetan-3-ol(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(4-aminophenyl)oxetan-3-ol(1111735-05-7)
• EPA Substance Registry System: 3-(4-aminophenyl)oxetan-3-ol(1111735-05-7)

Safety Data

• Hazardous Substances Data: 1111735-05-7(Hazardous Substances Data)

Usage

Chemical Class

Phenols

Description

White to off-white solid

Solubility

Soluble in most organic solvents

Applications

Synthesis of pharmaceuticals
Synthesis of agrochemicals
Potential applications in materials science

Biological Activities

May exhibit a range of biological activities

Potential

Interest for further research and development in the pharmaceutical industry.

Upstream product

• 1093878-32-0 3-(4-bromophenyl)oxetane-3-ol 
• 106-37-6 1.4-dibromobenzene 
• 147227-33-6 1-(4-bromophenyl)-2-(pyrrolidin-1-yl)diazene 
• 1402585-54-9 3-(4-(dibenzylamino)phenyl)oxetan-3-ol 
• 106-40-1 4-bromo-aniline 
• 65145-14-4 N,N-dibenzyl-4-bromoaniline 

Downstream Products

• 1402585-55-0 phenyl 4-(3-hydroxyoxetan-3-yl)phenylcarbamate 
• 1402581-41-2 1-[[5-tert-butyl-2-(3-chlorophenyl)-2H-pyrazol-3-yl]methyl]-3-[4-(3-hydroxyoxetan-3-yl)phenyl]urea 
• 1402581-42-3 1-[[2-(3-chlorophenyl)-5-(trifluoromethyl)-2H-pyrazol-3-yl]methyl]-3-[4-(3-hydroxyoxetan-3-yl)phenyl]urea 

Relevant articles and documents

COMPOUNDS USEFUL AS CSF1 MODULATORS

This invention relates to novel compounds and to pharmaceutical compositions comprising the novel compounds. More specifically, the invention relates to compounds useful as Colony Stimulating Factor 1 Receptor (cFMS) modulators (e.g. cFMS inhibitors). This invention also relates to processes for preparing the compounds, uses of the compounds in treatment and methods of treatment employing the compounds. Specifically, the invention relates to the use of the compounds for the treatment of cancer and autoimmune diseases.

SUBSTITUTED PYRAZOLYL-BASED CARBOXAMIDE AND UREA DERIVATIVES BEARING A PHENYL MOIETY SUBSTITUTED WITH AN O-CONTAINING GROUP AS VANILLOID RECEPTOR LIGANDS

The invention relates to substituted pyrazolyl-based carboxamide and urea derivatives of formula (Q) as vanilloid receptor ligands, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.